Atıf Formatları
Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. C. Oba Et Al. , "Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors," SKIN RESEARCH AND TECHNOLOGY , vol.29, no.3, 2023

Oba, M. C. Et Al. 2023. Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors. SKIN RESEARCH AND TECHNOLOGY , vol.29, no.3 .

Oba, M. C., AŞKIN, Ö., GÜNVER, M. G., Kocaarslan, G., ALİS, D. C., & ENGİN, B., (2023). Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors. SKIN RESEARCH AND TECHNOLOGY , vol.29, no.3.

Oba, Muazzez Et Al. "Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors," SKIN RESEARCH AND TECHNOLOGY , vol.29, no.3, 2023

Oba, Muazzez C. Et Al. "Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors." SKIN RESEARCH AND TECHNOLOGY , vol.29, no.3, 2023

Oba, M. C. Et Al. (2023) . "Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors." SKIN RESEARCH AND TECHNOLOGY , vol.29, no.3.

@article{article, author={Muazzez Cigdem Oba Et Al. }, title={Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors}, journal={SKIN RESEARCH AND TECHNOLOGY}, year=2023}